Your browser doesn't support javascript.
loading
Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
Le, Audrey; Farmakiotis, Dimitrios; Tarrand, Jeffrey J; Kontoyiannis, Dimitrios P.
Affiliation
  • Le A; Department of Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Farmakiotis D; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA dimitrios.farmakiotis@lifespan.org dkontoyi@mdanderson.org.
  • Tarrand JJ; Department of Laboratory Medicine, the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA dimitrios.farmakiotis@lifespan.org dkontoyi@mdanderson.org.
Article in En | MEDLINE | ID: mdl-28584138

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyenes / Azoles / Fluconazole / Amphotericin B / Candida glabrata / Echinocandins / Candidemia / Antifungal Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyenes / Azoles / Fluconazole / Amphotericin B / Candida glabrata / Echinocandins / Candidemia / Antifungal Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2017 Type: Article Affiliation country: United States